FibroBiologics
Company profile on P2PMarketData. FibroBiologics is a biotechnology company based in Houston, TX, founded in 2021. It has raised $5M through crowdfunding on StartEngine.
FibroBiologics is a clinical-stage cell therapy company based in Houston, Texas. It is developing fibroblast cell-based and fibroblast cell-derived product candidates designed to treat chronic diseases, including multiple sclerosis, degenerative disc disease, wound healing and cancer, as well as applications designed to extend the function of the thymus and spleen. It develops these therapies using fibroblasts rather than stem cells.
Frequently asked questions about FibroBiologics
How much funding has FibroBiologics raised?
FibroBiologics has raised $5M through crowdfunding across 1 round tracked by P2PMarketData, from 718 investors.
What is FibroBiologics' valuation?
FibroBiologics had an indicative valuation of $253M in its 2023 funding round.
Is FibroBiologics profitable?
No. FibroBiologics reported a net loss of $5.1M for fiscal year 2022.
How many employees does FibroBiologics have?
FibroBiologics reported 7 employees for fiscal year 2022.
When was FibroBiologics founded?
FibroBiologics was founded in April 2021.
Where is FibroBiologics based?
FibroBiologics is headquartered in Houston, Texas, United States, and is incorporated in Delaware, United States.
What industry is FibroBiologics in?
FibroBiologics operates in the Biotechnology industry within the Healthcare sector.